Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Here comes the selling pressure these license announcements bring.

Oct 03, 2008 06:11AM

What advantage does Swartz have by not letting the price run? If he is long and selling, he would be making alot more by simply letting the pps go before he sells. Now, after two years of selling, our pps has nowhere to go, new investors only have to look at a chart to see that our pps is artificially low and has been for quite some time. Would you buy into a situation like that? Swartz has sold alot more than 5 - 10 million shares, probably more like 20 million. This has been going on for over two years... I no longer think it is Swartz, but WTFDIK.

Share
New Message
Please login to post a reply